Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Nature Medicine
|
June 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
Journal for Immunotherapy of Cancer
|
June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Cancer Cell
|
August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Alexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Cancer Cell
|
August 13, 2024
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, et al.
Nature Medicine
|
January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial
David Marin, Ye Li, Rafet Basar, et al.
Cancer Cell
|
May 10, 2022
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Yared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, et al.
Blood Advances
|
July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
Rafet Basar, May Daher, Nadima Uprety, et al.
Frontiers in Immunology
|
May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
Mayela Mendt, May Daher, Rafet Basar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2021
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
Amanda Olson, Ruitao Lin, David Marin, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Nature Medicine
|
June 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
Journal for Immunotherapy of Cancer
|
June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Cancer Cell
|
August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Alexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Cancer Cell
|
August 13, 2024
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, et al.
Nature Medicine
|
January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial
David Marin, Ye Li, Rafet Basar, et al.
Cancer Cell
|
May 10, 2022
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Yared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, et al.
Blood Advances
|
July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
Rafet Basar, May Daher, Nadima Uprety, et al.
Frontiers in Immunology
|
May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
Mayela Mendt, May Daher, Rafet Basar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2021
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
Amanda Olson, Ruitao Lin, David Marin, et al.
Page
of 9